Regeneron Pharmaceuticals (REGN) Prepaid Assets (2009 - 2026)

Regeneron Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $620.9 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 32.42% year-over-year to $620.9 million; the TTM figure through Mar 2026 stood at $620.9 million (up 32.42% YoY), while the FY2025 annual figure was $474.8 million, up 35.97% from the prior year.
• Prepaid Assets was $620.9 million for Q1 2026 at Regeneron Pharmaceuticals, up from $474.8 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $681.9 million in Q2 2024 to a low of $349.2 million in Q4 2024.
• Historically, Prepaid Assets has averaged $481.9 million across 5 years, with a median of $446.4 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 98.92% in 2022, then sank 37.23% in 2023.
• A 5-year view of Prepaid Assets shows it stood at $411.2 million in 2022, then decreased by 5.98% to $386.6 million in 2023, then slipped by 9.67% to $349.2 million in 2024, then surged by 35.97% to $474.8 million in 2025, then jumped by 30.77% to $620.9 million in 2026.
• The last three Prepaid Assets figures came in at $620.9 million (Q1 2026), $474.8 million (Q4 2025), and $595.6 million (Q3 2025), per Business Quant data.